Indiana University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Indiana University sits in the top decile of US sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count).
Indiana University: 890 sponsored US clinical trials, 156 recruiting.
Indiana University sponsors 890 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 561 completed. 104 of these trials are in Phase 3-4 (later-stage) and 126 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimer Disease, with 11 trials.
Top-decile sponsor footprint
Indiana University ranks in the top decile of sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
561 of 688 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
890 total, page 13 of 18
Comparative Effectiveness of Primary Care-based Interventions for Pediatric ADHD
NCT02105142
Comparison of Subcutaneous INFIX and EXFIX for Anterior Pelvic Ring Fractures Requiring Stabilization
NCT02403154
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
NCT02008773
Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving Chemotherapy
NCT02097823
A Trial to Assess Optimal Postoperative Feeding Regiments Following Pyloromyotomy
NCT02415049
Improving Healthcare Systems for Access to Care by Underserved Patients
NCT02235597
Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease
NCT02194439
The Impact of Burnout on Patient-Centered Care: A Comparative Effectiveness Trial in Mental Health
NCT02146326
Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions
NCT02028325
Comparison of a Bilateral TAP Block and Preperitoneal Instillation of Local Anesthetic for a Total Extraperitoneal (TEP) Repair
NCT02036983
Comparison of AmblyzTM Glasses and Patching for Amblyopia
NCT01973348
Does Instrument-assisted Mobilization Influence Healthy, Short Achilles Tendons?
NCT07075172
N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults
NCT01962961
Computer Automation for Diagnosis and Management of Childhood Type 2 Diabetes
NCT01814787
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
NCT02213900
Conventional Direct Laryngoscopy Vs. Video Laryngoscopy With The C-MAC For Pyloromyotomy
NCT02775214
Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF)
NCT01925885
A Multicenter Phase I Study Evaluating the Addition of Bortezomib to an Established Acute Graft Versus Host Disease Prophylaxis Regimen in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients
NCT01926899
Aspiring to Awesome- Patient Preference Privacy Selections in EMR
NCT01862133
Effect of Octreotide on the Colonic Motility in Pediatric Patients
NCT01917773
Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis
NCT01912716
CYP2B6 Genetics and Drug Interactions in Healthy Volunteers
NCT02401256
At-home Auditory Training Clinical Trial
NCT01950013
Seizure Prophylaxis in Aneurysm Repair
NCT01974700
Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium
NCT02172898
Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantation
NCT01909401
The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia
NCT01874756
Buspirone for the Treatment of Traumatic Brain Injury (TBI) Irritability and Aggression
NCT01821690
Viral Pathogenesis of Early Cystic Fibrosis Lung Disease
NCT01973192
Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening
NCT01929083
Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant
NCT02079584
Telephone Support Program for Lung Cancer Patients and Their Family Caregivers
NCT01993550
Computer-Supported Management of Medical-Legal Issues Impacting Child Health
NCT01800669
Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
NCT01808534
Escalating Temporary Gastric Electrical Stimulation (GES) for Severe Gastroparesis
NCT02164591
Fingolimod in Schizophrenia Patients
NCT01779700
Encourage Healthy Families
NCT01823367
Dermabond Treatment for Gastric Variceal Bleeding
NCT02037659
The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome
NCT02112513
Patients' Opinions and Responses to the National Cancer Institute's Colorectal Cancer Risk Assessment Tool
NCT01803009
Evaluating Hearing Aid Service Delivery Models
NCT01788423
Indiana University Dementia Screening Trial
NCT01699503
Sphenopalatine Nerve Block for Headache Tx360
NCT01939314
EUS Ductal Evaluation in One Endoscopic Session for the Diagnosis of Exocrine Pancreas Disease
NCT01997476
Delivering Geospatial Intelligence to Health Care Providers
NCT01567228
Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures
NCT02037607
Treatment for Persistently Fatigued Cancer Survivors: A Randomized Controlled Trial With Biomarker Response
NCT01919853
A Pilot Study of Chlorthalidone Among Patients With Poorly Controlled Hypertension and CKD
NCT01750294
Single-shot TAP Block vs Continuous TAP Block
NCT02475031
Meaningful Activity Intervention for Persons With Mild Cognitive Impairment
NCT01843283
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 56 |
| Phase 2 | 70 |
| Phase 3 | 28 |
| Phase 4 | 76 |
Therapeutic Areas
What is open in the Indiana University pipeline
156 recruiting of 890 indexed (18% open); 561 completed (63%).
Phase mix: 104 late (III/IV) vs 126 early (I/II) (balanced across stages).
Top condition: Alzheimer Disease (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Indiana University: open-pipeline peers nationwide
Peers matched on 890 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 890 trials (± recruiting share)
- University of California, Los Angeles · 897 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Edwards Lifesciences · 18% recruiting · 57 trials
- University of South Florida · 17% recruiting · 252 trials
- VA Office of Research and Development · 17% recruiting · 1,668 trials
- ConvaTec · 18% recruiting · 17 trials
Related
What to do with this Indiana University page
890 registered trials is a research-attention snapshot, not an endorsement of Indiana University or any single study.
- 156 of Indiana University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimer Disease is the condition Indiana University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Indiana University pipeline card: 890 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.